Research reveals a connection between erectile dysfunction and various serious health conditions, including heart disease and metabolic syndrome. Chronic treatment with sildenafil has been shown to improve endothelial function and oxidative stress, suggesting potential benefits for cardiovascular indications.
Researchers have made significant breakthroughs in stem cell treatment options, including isolation of human spermatoogonial stem cells and use of autologous adipose-derived stem cells. Studies also show promise for engineered bladder tissue and muscle-derived cell injection in treating stress urinary incontinence.
Researchers found a strong correlation between initial PSA levels and future diagnosis of advanced disease. Men with high PSA levels had a higher risk of developing advanced disease, emphasizing the importance of early testing.
Researchers found a direct correlation between statin use and decreased prostate-specific antigen levels, as well as lower mortality rates from prostate cancer. The study suggests that increased statin use may be contributing to declining prostate cancer mortality rates in the US between 1993 and 2003.
Researchers will present and discuss new PET clinical uses, including cancer diagnosis and management, and comparison with CT for staging melanoma. The briefing also explores PET imaging agent Fluorocholine and its applications.
The 2000 Fall Research Meeting of the Society for the Study of Impotence features over 60 researchers presenting new peer-reviewed findings on sexual dysfunction, including new pharmaceutical treatments under development. Internationally renowned clinicians will also present Grand Master Lectures on key topics in sexual medicine.
Researchers present promising treatments for renal cell carcinoma using 5-aminolevulinic acid fluorescence detection, as well as a vaginal mucosal vaccine for recurrent urinary tract infections. Additionally, studies investigate the long-term health-related quality of life impacts of different prostate cancer therapies.
More than 1,500 original research studies on urologic diseases will be presented at the meeting, including prostate cancer, male and female sexual dysfunction, incontinence, and kidney stone disease. Key findings include data on prostate cancer costs, PSA screening, and outcomes after radical prostatectomy.
The American Urological Association has released new policy guidelines for prostate-specific antigen (PSA) testing, recommending a biopsy to confirm diagnosis when PSA levels are high or abnormal digital rectal examinations are performed. The guidelines also emphasize the importance of individualized decision-making and periodic testin...
The American Urological Association's 93rd Annual Meeting featured groundbreaking research on prostate cancer, erectile dysfunction, and kidney diseases. Researchers presented studies showcasing the importance of PSA testing in African American men and the effectiveness of sildenafil in treating erectile dysfunction.